SK Biopharm signs deal to commercialize anti-epileptic drug in Japan
SEOUL, Oct. 13 (Yonhap) -- SK Biopharmaceuticals Co., a biopharmaceutical affiliate of South Korea's SK Group, said Tuesday it has signed a deal with Japan's Ono Pharmaceutical Co. to develop and commercialize its anti-epileptic drug in Japan.
Under the deal, SK Biopharmaceuticals will receive 5 billion yen (US$47.4 million) as a down payment and will collect an additional 48.1 billion yen as a milestone payment after its cenobamate tablet earns health authorities' approval and becomes available in the Japanese market.
After commercialization, SK Biopharmaceuticals can collect royalty fees from Ono Pharmaceutical equivalent to a double-digit percentage of the product's sales, according to the company.
Cenobamate, branded as XCOPRI in the United States, last year earned the U.S. Food and Drug Administration's approval to be used as a treatment for partial-onset seizures in adults.
Currently, SK Biopharmaceuticals is pushing to initiate a phase 3 clinical trial for cenobamate in South Korea, Japan and China.
In Japan, SK Biopharmaceuticals will lead the phase 3 trial and will cooperate with Ono Pharmaceutical on getting drug approval and commercialization of the product.
kdon@yna.co.kr
(END)
-
New Defense Minister Lee takes office, warns of 'stern' response to possible N.K. provocations
-
(LEAD) Yoon taps ex-deputy NSA for spy chief
-
Gov't to significantly increase international flights to meet travel demand
-
(2nd LD) BTS wins three Billboard Music Awards, marking 6th year to win an award
-
Crypto investor probed over allegedly visiting house of Terraform's CEO
-
S. Korea to send condolence delegation to UAE over death of president
-
Yoon expresses hope for reopening of Seoul-Tokyo air route to bolster exchanges
-
(LEAD) N. Korea confirms first case of omicron variant of COVID-19: state media
-
Seoul's daily subway ridership hits pandemic-era high on eased restrictions
-
(5th LD) N.K. leader, wearing mask, chairs meeting on omicron outbreak
-
(LEAD) S. Korea looks into cryptocurrency market following TerraUSD, Luna crash
-
S. Korean volunteer fighter in Ukraine doesn't regret his action despite facing imprisonment at home
-
S. Korea's Black Eagles aerobatic team to perform in British air shows in July
-
(LEAD) Yoon names ex-Vice FM Cho as ambassador to U.S.
-
(LEAD) N. Korea reports 6 additional deaths amid COVID-19; military mobilized for drug supply